Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

NEK7 antibody (N-Term)

This Rabbit Polyclonal antibody specifically detects NEK7 in WB, ELISA and IHC. It exhibits reactivity toward Human.
Catalog No. ABIN2320633

Quick Overview for NEK7 antibody (N-Term) (ABIN2320633)

Target

See all NEK7 Antibodies
NEK7

Reactivity

  • 43
  • 34
  • 32
  • 6
  • 6
  • 6
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 54
  • 2
  • 2
Rabbit

Clonality

  • 55
  • 3
Polyclonal

Conjugate

  • 29
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This NEK7 antibody is un-conjugated

Application

  • 42
  • 20
  • 16
  • 13
  • 13
  • 11
  • 5
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
  • Binding Specificity

    • 15
    • 8
    • 7
    • 5
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term

    Cross-Reactivity

    Human

    Cross-Reactivity (Details)

    Calculated cross reactivity: Hu

    Characteristics

    NEK7, NT (Never in Mitosis A-related Kinase 7, NimA-related Protein Kinase 7, Serine/threonine Protein Kinase Nek7)

    Purification

    Purified by Protein G affinity chromatography.

    Immunogen

    Synthetic peptide selected from the N-terminal region of human NEK7 (KLH).

    Isotype

    IgG
  • Application Notes

    Optimal working conditions should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Supplied as a liquid in PBS, 0.09 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    -20°C
  • Target

    NEK7

    Alternative Name

    NEK7

    UniProt

    Q8TDX7

    Pathways

    Inflammasome
You are here:
Chat with us!